P. Schelling

3.4k total citations
69 papers, 2.4k citations indexed

About

P. Schelling is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, P. Schelling has authored 69 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cardiology and Cardiovascular Medicine, 25 papers in Molecular Biology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in P. Schelling's work include Renin-Angiotensin System Studies (19 papers), Receptor Mechanisms and Signaling (12 papers) and Cardiac Ischemia and Reperfusion (10 papers). P. Schelling is often cited by papers focused on Renin-Angiotensin System Studies (19 papers), Receptor Mechanisms and Signaling (12 papers) and Cardiac Ischemia and Reperfusion (10 papers). P. Schelling collaborates with scholars based in Germany, United States and Switzerland. P. Schelling's co-authors include Detlev Ganten, Hans Fischer, Ursula Ganten, J. S. Hutchinson, Thilo Stehle, Léonardo Scapozza, Terence S. Dermody, Norbert Beier, D. Felix and Jacquelyn A. Campbell and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

P. Schelling

68 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Schelling Germany 28 1.1k 968 368 273 236 69 2.4k
Michaela Kühn Germany 40 2.0k 1.8× 2.0k 2.1× 464 1.3× 351 1.3× 873 3.7× 122 4.9k
Kleber G. Franchini Brazil 33 1.2k 1.1× 1.4k 1.5× 177 0.5× 128 0.5× 501 2.1× 120 3.2k
Edward Karpinski Canada 26 292 0.3× 1.1k 1.1× 157 0.4× 443 1.6× 219 0.9× 98 2.4k
Bernard Robaye Belgium 40 569 0.5× 1.9k 1.9× 155 0.4× 320 1.2× 643 2.7× 100 4.7k
Rebecca A. Lew Australia 26 1.0k 0.9× 1.2k 1.2× 631 1.7× 602 2.2× 179 0.8× 70 3.1k
Herman Van Belle Belgium 30 404 0.4× 1.4k 1.4× 342 0.9× 380 1.4× 365 1.5× 86 3.2k
Paula Sherman United States 21 560 0.5× 1.1k 1.2× 133 0.4× 175 0.6× 1.4k 6.0× 34 3.4k
Jimmy Calaycay United States 21 375 0.3× 1.5k 1.5× 175 0.5× 266 1.0× 1.7k 7.4× 27 3.9k
Jane F Armstrong United Kingdom 19 282 0.3× 2.2k 2.3× 204 0.6× 561 2.1× 346 1.5× 30 4.3k
Eef Harmsen Canada 25 488 0.4× 1.0k 1.1× 179 0.5× 93 0.3× 183 0.8× 54 2.0k

Countries citing papers authored by P. Schelling

Since Specialization
Citations

This map shows the geographic impact of P. Schelling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Schelling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Schelling more than expected).

Fields of papers citing papers by P. Schelling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Schelling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Schelling. The network helps show where P. Schelling may publish in the future.

Co-authorship network of co-authors of P. Schelling

This figure shows the co-authorship network connecting the top 25 collaborators of P. Schelling. A scholar is included among the top collaborators of P. Schelling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Schelling. P. Schelling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gerth, Klaus, et al.. (2006). Nitric Oxide Scavenging by Hydroxocobalamin May Account for Its Hemodynamic Profile. Clinical Toxicology. 44(sup1). 29–36. 53 indexed citations
2.
Dalgarno, David C., Thilo Stehle, Surinder S. Narula, et al.. (2005). Structural Basis of Src Tyrosine Kinase Inhibition with a New Class of Potent and Selective Trisubstituted Purine‐based Compounds. Chemical Biology & Drug Design. 67(1). 46–57. 65 indexed citations
3.
Gumina, Richard J., et al.. (2005). Cardioprotective-Mimetics Reduce Myocardial Infarct Size in Animals Resistant to Ischemic Preconditioning. Cardiovascular Drugs and Therapy. 19(5). 315–322. 8 indexed citations
4.
Kretschmer, B. D., et al.. (2004). Modulatory role of food, feeding regime and physical exercise on body weight and insulin resistance. Life Sciences. 76(14). 1553–1573. 58 indexed citations
5.
6.
Forrest, J. Craig, Jacquelyn A. Campbell, P. Schelling, Thilo Stehle, & Terence S. Dermody. (2003). Structure-Function Analysis of Reovirus Binding to Junctional Adhesion Molecule 1. Journal of Biological Chemistry. 278(48). 48434–48444. 63 indexed citations
7.
Russ, Pamela, P. Schelling, Léonardo Scapozza, et al.. (2003). Synthesis and Biological Evaluation of 5-Substituted Derivatives of the Potent Antiherpes Agent (north)-Methanocarbathymine. Journal of Medicinal Chemistry. 46(23). 5045–5054. 37 indexed citations
8.
Stowe, David F., James S. Heisner, Jianzhong An, et al.. (2002). Inhibition of Na+/H+ isoform-1 exchange protects hearts perfused after 6-hour cardioplegic cold storage. The Journal of Heart and Lung Transplantation. 21(3). 374–382. 14 indexed citations
9.
Sulpizi, Marialore, P. Schelling, Gerd Folkers, Paolo Carloni, & Léonardo Scapozza. (2001). The Rational of Catalytic Activity of Herpes Simplex Virus Thymidine Kinase. Journal of Biological Chemistry. 276(24). 21692–21697. 29 indexed citations
10.
Schelling, P., Gerd Folkers, & Léonardo Scapozza. (2001). A Spectrophotometric Assay for Quantitative Determination of kcat of Herpes Simplex Virus Type 1 Thymidine Kinase Substrates. Analytical Biochemistry. 295(1). 82–87. 33 indexed citations
11.
Beier, N. F., et al.. (2001). Cardioprotective effects of the NHE1-inhibitor EMD 87580. Journal of Molecular and Cellular Cardiology. 33(6). A10–A10. 1 indexed citations
12.
Vogt, Joachim, Remo Perozzo, A.E. Prota, et al.. (2000). Nucleoside binding site ofHerpes simplex type 1 thymidine kinase analyzed by X-ray crystallography. Proteins Structure Function and Bioinformatics. 41(4). 545–553. 54 indexed citations
13.
Gumina, Richard J., Norbert Beier, P. Schelling, & Garrett J. Gross. (2000). Inhibitors of Ischemic Preconditioning Do Not Attenuate Na+/H+ Exchange Inhibitor Mediated Cardioprotection. Journal of Cardiovascular Pharmacology. 35(6). 949–953. 17 indexed citations
14.
Mederski, Werner W. K. R., Dieter Dorsch, Soheila Anzali, et al.. (1998). 3. Endothelin antagonists: discovery of EMD 122946, a highly potent and orally active ETA selective antagonist. Bioorganic & Medicinal Chemistry Letters. 8(13). 1771–1776. 9 indexed citations
15.
16.
Haeusler, Guenther, et al.. (1997). In Vivo Evidence of Positive Inotropism of EMD 57 033 Through Calcium Sensitization. Journal of Cardiovascular Pharmacology. 29(5). 647–655. 14 indexed citations
17.
18.
Rohmann, Sven, et al.. (1994). Involvement of ATP-sensitive potassium channels in preconditioning protection. Basic Research in Cardiology. 89(6). 563–576. 35 indexed citations
19.
Mederski, Werner W. K. R., et al.. (1994). Non-Peptide Angiotensin II Receptor Antagonists: Synthesis and Biological Activity of a Series of Novel 4,5-Dihydro-4-oxo-3H-imidazo[4,5-c]pyridine Derivatives. Journal of Medicinal Chemistry. 37(11). 1632–1645. 20 indexed citations
20.
Haeusler, G., et al.. (1992). Pharmacological basis for antihypertensive therapy with a novel dopamine agonist. European Heart Journal. 13(suppl D). 129–135. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michaela Kühn Breakdown of academic impact, for papers by Kleber G. Franchini Breakdown of academic impact, for papers by Edward Karpinski Breakdown of academic impact, for papers by Bernard Robaye Breakdown of academic impact, for papers by Rebecca A. Lew Breakdown of academic impact, for papers by Herman Van Belle Breakdown of academic impact, for papers by Paula Sherman Breakdown of academic impact, for papers by Jimmy Calaycay Breakdown of academic impact, for papers by Jane F Armstrong Breakdown of academic impact, for papers by Eef Harmsen
Rankless by CCL
2026